Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Propranolol reduces cognitive deficits, amyloid ß levels, tau phosphorylation and insulin resistance in response to chronic corticosterone administration.

Propranolol reduces cognitive deficits, amyloid ß levels, tau phosphorylation and insulin resistance in response to chronic corticosterone administration. Int J Neuropsychopharmacol. 2013 Jul; 16(6):1351-60.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.